Collaborative effort will accelerate development of novel therapies for underserved diseases involving the central nervous system

Minnesota-based Company to Present at Late Breaking Session during Congress of Neurological Surgeons

Minnetronix is developing a product that removes contaminants in the cerebral spinal fluid after a hemorrhagic stroke.